Advertisement

Is There a Role for Triple Endoscopy in the Staging of Head and Neck Cancer?

  • Thomas S. Y. Ho
  • Raymond K. Y. TsangEmail author
Chapter
Part of the Difficult Decisions in Surgery: An Evidence-Based Approach book series (DDSURGERY)

Abstract

Triple endoscopy had been a traditional investigation utilized in detecting synchronous and/or metachronous tumors along the upper aerodigestive tract in patients with head and neck squamous cell carcinomas, but the routine use of it had been debatable. The rate of synchronous esophageal tumors ranged from 0% to 30.4% in all literature. There was a trend towards a lower rate of occurrence in the Western literature in recent years while most Asian studies still reported a substantial rate of occurrence, especially in patients with hypopharyngeal cancer and among alcoholics. Esophagoscopy is therefore still recommended widely as a staging tool especially in Asian studies. In comparison, there was a lower rate of synchronous lung cancers in the literature, ranging from 0% to at most 1.5%. Most studies didn’t suggest routine use of bronchoscopy as it can be potentially replaced by imaging modalities such as computed tomography scan.

Keywords

Triple endoscopy Head and neck squamous cell carcinomas Second primary cancers Synchronous cancer Upper aerodigestive tract Field cancerization 

References

  1. 1.
    Billroth T, Von Winiwarter A. A general surgical pathology and therapeutics. New York: Appleton; 1883.Google Scholar
  2. 2.
    Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6:963–8.CrossRefGoogle Scholar
  3. 3.
    Bhattacharyya N, Nayak JK. Survival outcomes for second primary head and neck cancer: a matched analysis. Otolaryngol Head Neck Surg. 2005;132:63–8.CrossRefGoogle Scholar
  4. 4.
    Schwarz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinoma. Cancer. 1994;74:1933–8.CrossRefGoogle Scholar
  5. 5.
    Di Martino E, Sellhaus B, Hausmann R, et al. Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol. 2002;116:831–8.CrossRefGoogle Scholar
  6. 6.
    Chung CS, Liao LJ, Lo WC, et al. Risk factors for second primary neoplasia of esophagus in newly diagnosed head and neck cancer patients. BMC Gastroenterol. 2013;13:154.CrossRefGoogle Scholar
  7. 7.
    McGuirt WF. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope. 1982;92:569–76.CrossRefGoogle Scholar
  8. 8.
    Maisel RH, Vermeersch H. Panendoscopy for second primaries in head and neck cancer. Ann Otol Rhinol Laryngol. 1981;90:460–4.CrossRefGoogle Scholar
  9. 9.
    Abemayor E, Moore DM, Hanson DG. Identification of synchronous esophageal tumors in patients with head and neck cancer. J Surg Oncol. 1988;38:94–6.CrossRefGoogle Scholar
  10. 10.
    Colt HG, Matsuo T. Hospital charges attributable to bronchoscopy-related complications in outpatients. Respiration. 2001;68:67–72.CrossRefGoogle Scholar
  11. 11.
    Ginzburg L, Greenwald D, Cohen J. Complications of endoscopy. Gastrointest Endosc Clin N Am. 2007;17:405–32.CrossRefGoogle Scholar
  12. 12.
    Soni A, Sampliner RE, Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol. 2000;95:2086–93.CrossRefGoogle Scholar
  13. 13.
    Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointest Endosc. 2011;74:610–24.CrossRefGoogle Scholar
  14. 14.
    Cianfriglia F, Di Gregorio DA, Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol. 1999;35:157–63.CrossRefGoogle Scholar
  15. 15.
    Tincani AJ, Brandalise N, Altemani A, Scanavini RC, Valério JB, et al. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% Lugol dye solution in patients with head and neck cancer. Head Neck. 2000;22:170–4.CrossRefGoogle Scholar
  16. 16.
    Davidson J, Gilbert R, Irish J, Witterick I, Brown D, Birt D, Freeman J, Gullane P. The role of panendoscopy in the management of mucosal head and neck malignancy—a prospective evaluation. Head Neck. 2000;22:449–54.CrossRefGoogle Scholar
  17. 17.
    Stoeckli SJ, Zimmermann R, Schmid S. Role of routine panendoscopy in cancer of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001;124:208–12.CrossRefGoogle Scholar
  18. 18.
    Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc. 2002;56(4):517–21.CrossRefGoogle Scholar
  19. 19.
    Scherübl H, von Lampe B, Faiss S, et al. Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer. 2002;86(2):239–43.CrossRefGoogle Scholar
  20. 20.
    Guardiola E, Chaigneau L, Villanueva C, Pivot X. Is there still a role for triple endoscopy as part of staging for head and neck cancer? Curr Opin Otolaryngol Head Neck Surg. 2006;14(2):85–8.PubMedGoogle Scholar
  21. 21.
    Hujala K, Sipilä J, Grenman R. Panendoscopy and synchronous primary tumors in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2005;262(1):17–20.CrossRefGoogle Scholar
  22. 22.
    Hashimoto CL, Iriya K, Baba ER, et al. Lugol’s dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol. 2005;100(2):275–82.CrossRefGoogle Scholar
  23. 23.
    Moschler O, Spahn TW, Middelberg-Bisping C, et al. Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer. Digestion. 2006;73(2–3):160–6.CrossRefGoogle Scholar
  24. 24.
    Tsao GJ, Damrose EJ. Complications of esophagoscopy in an academic training program. Otolaryngol Head Neck Surg. 2010;142(4):500–4.CrossRefGoogle Scholar
  25. 25.
    Chuang SC, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123(10):2390–6.CrossRefGoogle Scholar
  26. 26.
    Chow TL, Lee DT, Choi CY, Chan TT, Lam SH. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis. Arch Otolaryngol Head Neck Surg. 2009;135:882–5.CrossRefGoogle Scholar
  27. 27.
    Lee CT, Chang CY, Lee YC, Tai CM, Wang WL, et al. Narrow-band imaging with magnifying endoscopy for the screening of esophageal cancer in patients with primary head and neck cancers. Endoscopy. 2010;42:613–9.CrossRefGoogle Scholar
  28. 28.
    Rodriguez-Bruno K, Ali MJ, Wang SJ. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head Neck. 2011;33:949–53.CrossRefGoogle Scholar
  29. 29.
    Rennemo E, Zätterström U, Boysen M. Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy. Laryngoscope. 2011;121:304–9.CrossRefGoogle Scholar
  30. 30.
    Ikawa H, Tonogi M, Yamane GY, Yamauchi T, Tanaka Y, Sato M, Matsui J, Ando N, Katakura A. Upper gastrointestinal tract cancers as double-cancers in elderly patients with oral squamous cell carcinoma. Bull Tokyo Dent Coll. 2012;53(1):9–16.CrossRefGoogle Scholar
  31. 31.
    Priante AVM, Gross JL, Sztokfisz CZ, et al. Diagnosis of second primary tumor and long-term survival after single initial triple endoscopy in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 2014;271:2285.CrossRefGoogle Scholar
  32. 32.
    Su YY, Chen WC, Chuang HC, et al. Effect of routine esophageal screening in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(4):350–4.CrossRefGoogle Scholar
  33. 33.
    Hung SH, Tsai MC, Liu TC, Lin HC, Chung SD. Routine endoscopy for esophageal cancer is suggestive for patients with oral, oropharyngeal and hypopharyngeal cancer. PLoS One. 2013;8:e72097.CrossRefGoogle Scholar
  34. 34.
    Shahangian A, Damrose EJ. Bronchoscopy in panendoscopy: review and assessment. J Laryngol Otol. 2015;129(12):1220–3.CrossRefGoogle Scholar
  35. 35.
    Krishnatreya M, Rahman T, Kataki AC, Lahkar K. Synchronous primary cancers in the head and neck region and upper aero digestive tract: role of triple endoscopy. Indian J Cancer. 2015;52:53–6.CrossRefGoogle Scholar
  36. 36.
    Koo K, Harris R, Wiesenfeld D, Iseli TA. A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue. J Laryngol Otol. 2015;129(S1):S27–31.CrossRefGoogle Scholar
  37. 37.
    Huang YC, Lee YC, Tseng PH, et al. Regular screening of esophageal cancer for 248 newly diagnosed hypopharyngeal squamous cell carcinoma by unsedated transnasal esophagogastroduodenoscopy. Oral Oncol. 2016;55:55–60.CrossRefGoogle Scholar
  38. 38.
    McGarey PO, O’Rourke AK, Owen SR, et al. Rigid esophagoscopy for head and neck cancer staging and the incidence of synchronous esophageal malignant neoplasms. JAMA Otolaryngol Head Neck Surg. 2016;142(1):40–5.CrossRefGoogle Scholar
  39. 39.
    Haughey GA, Arfken CL, Harvey JB. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol. 1992;101:105–12.CrossRefGoogle Scholar
  40. 40.
    Zhang H-Z, Jin G-F, Shen H-B. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31(6):281–6.CrossRefGoogle Scholar
  41. 41.
    Boiselle PM. Computed tomography screening for lung cancer. JAMA. 2013;309:1163–70.CrossRefGoogle Scholar
  42. 42.
    National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368:1980–91.CrossRefGoogle Scholar
  43. 43.
    de Monès E, Bertolus C, Salaun PY, Dubrulle F, Ferrié JC, Temam S, Chevalier D, Vergez S, Lagarde F, Schultz P, Lapeyre M, Barry B, Tronche S, de Raucourt D, Morinière S. Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelines. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130:107–12.CrossRefGoogle Scholar
  44. 44.
    Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612–9.CrossRefGoogle Scholar
  45. 45.
    Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758–62.CrossRefGoogle Scholar
  46. 46.
    Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.CrossRefGoogle Scholar
  47. 47.
    Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.CrossRefGoogle Scholar
  48. 48.
    Morris LG, Sikora AG, Patel SG, et al. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011;29:739–46.CrossRefGoogle Scholar
  49. 49.
    Peck BW, Dahlstrom KR, Gan SJ, et al. Low risk of second primary malignancies among never smokers with human papilloma-virus-associated index oropharyngeal cancers. Head Neck. 2012;35(6):794–9.CrossRefGoogle Scholar
  50. 50.
    D’Souza G, Kreimer A, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.CrossRefGoogle Scholar
  51. 51.
    Rosenquist K, Wennerberg J, Annertz K, et al. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol. 2007;127:980–7.CrossRefGoogle Scholar
  52. 52.
    Hansson BG, Resenquist K, Antonsson A, et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 2005;125:1337–44.CrossRefGoogle Scholar
  53. 53.
    Jain KS, Sikora AG, Baxi SS, Morris LG. Synchronous cancers in patients with head and neck cancer. Cancer. 2013;119:1832–7.CrossRefGoogle Scholar
  54. 54.
    Saito Y, Ebihara Y, Ushiku T, Omura G, Kobayashi K, Ando M, Sakamoto T, Fukayama M, Yamasoba T, Asakage T. Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinoma. Jpn J Clin Oncol. 2014;44(6):564–9.CrossRefGoogle Scholar
  55. 55.
    Xu CC, Biron VL, Puttagunta L, Seikaly H. HPV Status and second primary tumours in oropharyngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2013;42:36.CrossRefGoogle Scholar
  56. 56.
    Wang W, Wang Y, Chang C, Lo J, Kuo Y, Hwang T, Wang C, Mo L, Lin J, Lee C. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer. Laryngoscope. 2016;126:1097–102.CrossRefGoogle Scholar
  57. 57.
    Ecimovic P, Pompe-Kirn V. Second primary cancers in laryngeal cancer patients in Slovenia, 1961–1996. Eur J Cancer. 2002;38:1254–60.CrossRefGoogle Scholar
  58. 58.
    Rafferty MA, O’Dwyer TP. Secondary primary malignancies in head and neck squamous cell carcinoma. J Laryngol Otol. 2001;115:988–91.CrossRefGoogle Scholar
  59. 59.
    Adam S, Baum RP, Stuckensen T, et al. Prospective comparison of F-18-FDG-PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255–60.CrossRefGoogle Scholar
  60. 60.
    Kau RJ, Alexiou C, Laubenbacher C, et al. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in routine clinical setting. Arch Otolaryngol Head Neck Surg. 1999;125:1322–8.CrossRefGoogle Scholar
  61. 61.
    Fleming AJ Jr, Smith SP Jr, Paul CM, Hall NC, Daly BT, Agrawal A, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope. 2007;117:1173–9.CrossRefGoogle Scholar
  62. 62.
    Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg. 2007;137:130–7.CrossRefGoogle Scholar
  63. 63.
    Connell CA, Corry J, Milner AD, Hogg A, Hicks RJ, Rischin D, et al. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck. 2007;29:986–95.CrossRefGoogle Scholar
  64. 64.
    Schwartz DL, Rajendran J, Yueh B, Coltrera M, Anzai Y, Krohn K, et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg. 2003;129:1173–8.CrossRefGoogle Scholar
  65. 65.
    Strobel K, et al. Head and neck squamous cell carcinoma (HNSCC)—detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging. 2009;36(6):919–27.CrossRefGoogle Scholar
  66. 66.
    Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. 18F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 2010;32:319–25.PubMedGoogle Scholar
  67. 67.
    Inoue H, Kumagai Y, Yoshida T, Kawano T, Endo M, Iwai T. High-magnification endoscopic diagnosis of the superficial esophageal cancer. Dig Endosc. 2000;12(s1):32–5.CrossRefGoogle Scholar
  68. 68.
    Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc. 2004;59(2):288–95.CrossRefGoogle Scholar
  69. 69.
    Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, Omori T, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2000;28(9):1566–72.CrossRefGoogle Scholar
  70. 70.
    Hospital Authority, Hong Kong Cancer Registry web site. www3.ha.org.hk/cancereg/statistics.html.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Otorhinolaryngology, Department of SurgeryThe University of Hong Kong, Queen Mary HospitalHong KongHong Kong

Personalised recommendations